Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection.
An assay method for the quantification of cyclophosphamide (CY) and five metabolites from human plasma is presented. The procedure is adapted to the chemical properties of the compounds of interest: non-polar compounds are extracted into methylene chloride, concentrated and analyzed by GC-NPD after derivatization, and the remaining aqueous fraction is deproteinated with acetonitrile-methanol prior to separation via reversed-phase HPLC and detection using atmospheric pressure ionization (API)-MS. Standard curves are linear over the required range and reproducible over five months. Plasma concentration-time profiles of CY and metabolites from a patient receiving CY by intravenous infusion (60 mg/kg, once a day for two days) are presented.
Kalhorn
T F
TF
Department of Pharmaceutics, University of Washington, Seattle 98195, USA.
Ren
S
S
Howald
W N
WN
Lawrence
R F
RF
Slattery
J T
JT
D018906:Antineoplastic Agents, Alkylating / Q000097:blood*; D002849:Chromatography, Gas / Q000379:methods*; D002853:Chromatography, Liquid / Q000379:methods*; D003520:Cyclophosphamide / Q000097:blood*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D009584:Nitrogen / Q000032:analysis; D010758:Phosphorus / Q000032:analysis
D018906:Antineoplastic Agents, Alkylating; D010758:Phosphorus; D003520:Cyclophosphamide; D009584:Nitrogen